Viewing Study NCT01053858

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-06-10 @ 10:37 AM
Study NCT ID: NCT01053858
Status: COMPLETED
Last Update Posted: 2010-01-22
First Post: 2010-01-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision
Sponsor: Hallym University Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bevacizumab,triamcinolone, intravitreal injection View